Compounds > losartan

losartan and puromycin aminonucleoside

losartan has been researched along with puromycin aminonucleoside in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Itoh, N; Kawao, M; Okamoto, H; Tujii, H; Yayama, K1
Fujimoto, S; Fukuda, A; Iwatsubo, S; Kawachi, H; Kitamura, K1

Other Studies

2 other study(ies) available for losartan and puromycin aminonucleoside

ArticleYear
Dup 753 prevents the development of puromycin aminonucleoside-induced nephrosis.
    European journal of pharmacology, 1993, May-19, Volume: 236, Issue:2

    Topics: Angiotensin II; Animals; Biphenyl Compounds; Blood Urea Nitrogen; Cholesterol; Imidazoles; Losartan; Male; Nephrosis; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles

1993
Effects of mineralocorticoid and angiotensin II receptor blockers on proteinuria and glomerular podocyte protein expression in a model of minimal change nephrotic syndrome.
    Nephrology (Carlton, Vic.), 2010, Volume: 15, Issue:3

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Disease Models, Animal; Eplerenone; Fluorescent Antibody Technique; Intracellular Signaling Peptides and Proteins; Losartan; Male; Membrane Proteins; Mineralocorticoid Receptor Antagonists; Nephrosis, Lipoid; Podocytes; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Sialoglycoproteins; Spironolactone; Time Factors

2010